|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Remeasurement of convertible preferred stock warrant liability | |||||
| Gain on partial termination of lease | |||||
| Gain on lease modification | |||||
| Stock-based compensation | |||||
| Depreciation and amortization | |||||
| Changes in fair value of derivative liabilities | |||||
| Reduction of transaction costs allocated to derivative liabilities upon Business Combination | |||||
| Non-cash interest expense | |||||
| Asset impairment charges | |||||
| Other non-cash expenses | |||||
| Inventory write-downs | |||||
| Loss on extinguishment of debt | |||||
| Impairment of operating lease right-of-use asset | |||||
| Other non-cash expenses (income) | |||||
| Changes in operating assets and liabilities: | |||||
| Inventory | |||||
| Prepaids and other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Deferred revenue | |||||
| Operating lease right-of-use assets and liabilities | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Cash paid for acquisitions | |||||
| Proceeds from sale of property and equipment | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from the issuance of common stock | |||||
| Proceeds from the issuance of debt | |||||
| Payment of issuance costs related to SEPA | |||||
| Payment of debt issuance costs | |||||
| Payment on finance agreement | |||||
| Repayment of debt and Structural Derivative Liability | |||||
| Payment of costs to extinguish debt | |||||
| Net proceeds (payments) related to stock-based award activities | |||||
| Payment of transaction costs related to Business Combination, redeemable convertible preferred stock and settlement of HGI Additional Shares liability | |||||
| Payment of transaction costs related to redeemable convertible preferred stock | |||||
| Payments related to stock-based award activities, net | |||||
| Proceeds from issuance under employee stock purchase plan | |||||
| Payment of debt modification costs | |||||
| Net cash used in financing activities | |||||
| Cash, beginning of the period | |||||
| Cash, end of the period | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental Disclosure | |||||
| Cash paid for taxes | |||||
| Cash paid for interest | |||||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities | |||||
| Purchase of property and equipment in accounts payable and accrued liabilities | |||||
| Debt issuance costs in accounts payable and accrued liabilities | |||||
| Transaction costs and convertible preferred stock included in accounts payable and accrued liabilities | |||||
| Assumption of derivative liabilities upon Business Combination | |||||
| Initial measurement of Structural Derivative Liability recorded as debt fees | |||||
| Initial measurement of common stock recorded as debt fees | |||||
| Initial measurement of common stock warrants recorded as debt fees | |||||
| Transaction costs and preferred stock issuance costs in accounts payable and accrued liabilities | |||||
| Settlement of HGI Additional Shares liability | |||||
| Partial settlement of Earnout due to cancellation of shares | |||||
| Conversion of contingently redeemable convertible common stock and preferred stock to common stock | |||||
| Reclassification of Grove's preferred stock warrant liability to equity | |||||
| Net exercise of preferred stock warrants | |||||
| Cost of debt extinguishment in accrued liabilities | |||||
| Financing agreement entered into for prepaid insurance | |||||
| Redeemable convertible preferred stock issuance costs in accounts payable and accrued liabilities | |||||
| Cancellation of Volition Warrants | |||||
| Reduction in transaction costs allocated to equity instruments | |||||
| Vesting of early exercised stock options | |||||
Loading...